378 related articles for article (PubMed ID: 32516772)
21. Laboratory characteristics of patients infected with the novel SARS-CoV-2 virus.
Skevaki C; Fragkou PC; Cheng C; Xie M; Renz H
J Infect; 2020 Aug; 81(2):205-212. PubMed ID: 32579986
[TBL] [Abstract][Full Text] [Related]
22. Impact of SARS-CoV-2 infection on neurodegenerative and neuropsychiatric diseases: a delayed pandemic?
Serrano-Castro PJ; Estivill-Torrús G; Cabezudo-García P; Reyes-Bueno JA; Ciano Petersen N; Aguilar-Castillo MJ; Suárez-Pérez J; Jiménez-Hernández MD; Moya-Molina MÁ; Oliver-Martos B; Arrabal-Gómez C; Rodríguez de Fonseca F
Neurologia (Engl Ed); 2020 May; 35(4):245-251. PubMed ID: 32364119
[TBL] [Abstract][Full Text] [Related]
23. Coronavirus Disease 2019: Coronaviruses and Kidney Injury.
Lv W; Wu M; Ren Y; Zeng N; Deng P; Zeng H; Zhang Q; Wu Y
J Urol; 2020 Nov; 204(5):918-925. PubMed ID: 32693711
[TBL] [Abstract][Full Text] [Related]
24. Immune response to SARS-CoV-2 and mechanisms of immunopathological changes in COVID-19.
Azkur AK; Akdis M; Azkur D; Sokolowska M; van de Veen W; Brüggen MC; O'Mahony L; Gao Y; Nadeau K; Akdis CA
Allergy; 2020 Jul; 75(7):1564-1581. PubMed ID: 32396996
[TBL] [Abstract][Full Text] [Related]
25. Clinical Characteristics of Patients with Severe Pneumonia Caused by the SARS-CoV-2 in Wuhan, China.
Wang Y; Zhou Y; Yang Z; Xia D; Hu Y; Geng S
Respiration; 2020; 99(8):649-657. PubMed ID: 32841948
[TBL] [Abstract][Full Text] [Related]
26. Cross-Talk Between Key Players in Patients with COVID-19 and Ischemic Stroke: A Review on Neurobiological Insight of the Pandemic.
Kaushik P; Kaushik M; Parveen S; Tabassum H; Parvez S
Mol Neurobiol; 2020 Dec; 57(12):4921-4928. PubMed ID: 32813238
[TBL] [Abstract][Full Text] [Related]
27. Clinical characteristics of 140 patients infected with SARS-CoV-2 in Wuhan, China.
Zhang JJ; Dong X; Cao YY; Yuan YD; Yang YB; Yan YQ; Akdis CA; Gao YD
Allergy; 2020 Jul; 75(7):1730-1741. PubMed ID: 32077115
[TBL] [Abstract][Full Text] [Related]
28. Viral and host factors related to the clinical outcome of COVID-19.
Zhang X; Tan Y; Ling Y; Lu G; Liu F; Yi Z; Jia X; Wu M; Shi B; Xu S; Chen J; Wang W; Chen B; Jiang L; Yu S; Lu J; Wang J; Xu M; Yuan Z; Zhang Q; Zhang X; Zhao G; Wang S; Chen S; Lu H
Nature; 2020 Jul; 583(7816):437-440. PubMed ID: 32434211
[TBL] [Abstract][Full Text] [Related]
29. Endothelial activation and dysfunction in metabolic syndrome, type 2 diabetes and coronavirus disease 2019.
Hayden MR
J Int Med Res; 2020 Jul; 48(7):300060520939746. PubMed ID: 32722979
[TBL] [Abstract][Full Text] [Related]
30. Recent exposure to smoking and COVID-19.
Landoni G; Moro M; Belletti A; Rovere-Querini P; Veronesi G; Ruggeri A; Lembo R; Dalessandro G; Galbiati C; Serpa Neto A; Zangrillo A
Crit Care Resusc; 2020 Sep; 22(3):253-256. PubMed ID: 32900332
[No Abstract] [Full Text] [Related]
31. Cellular senescence as a potential mediator of COVID-19 severity in the elderly.
Nehme J; Borghesan M; Mackedenski S; Bird TG; Demaria M
Aging Cell; 2020 Oct; 19(10):e13237. PubMed ID: 32955770
[TBL] [Abstract][Full Text] [Related]
32. Inflammation resolution: a dual-pronged approach to averting cytokine storms in COVID-19?
Panigrahy D; Gilligan MM; Huang S; Gartung A; Cortés-Puch I; Sime PJ; Phipps RP; Serhan CN; Hammock BD
Cancer Metastasis Rev; 2020 Jun; 39(2):337-340. PubMed ID: 32385712
[TBL] [Abstract][Full Text] [Related]
33. Spectrum of Neurological Manifestations in Covid-19: A Review.
Garg RK
Neurol India; 2020; 68(3):560-572. PubMed ID: 32643664
[TBL] [Abstract][Full Text] [Related]
34. Implications of Low-grade Inflammation in SARS-CoV-2 Immunopathology.
Suárez-Reyes A; Villegas-Valverde CA
MEDICC Rev; 2021 Apr; 23(2):42. PubMed ID: 33974614
[TBL] [Abstract][Full Text] [Related]
35. IL-1 induces throboxane-A2 (TxA2) in COVID-19 causing inflammation and micro-thrombi: inhibitory effect of the IL-1 receptor antagonist (IL-1Ra).
Conti P; Caraffa A; Gallenga CE; Ross R; Kritas SK; Frydas I; Younes A; Di Emidio P; Ronconi G; Toniato E
J Biol Regul Homeost Agents; 2020 Sep-Oct,; 34(5):1623-1627. PubMed ID: 32744052
[TBL] [Abstract][Full Text] [Related]
36. COVID-19 and Cardiovascular Health Among Patients with Cancer.
Palaskas NL; Koutroumpakis E; Deswal A
Curr Cardiol Rep; 2020 Oct; 22(12):171. PubMed ID: 33040241
[TBL] [Abstract][Full Text] [Related]
37. Cytokine storm induced by SARS-CoV-2.
Song P; Li W; Xie J; Hou Y; You C
Clin Chim Acta; 2020 Oct; 509():280-287. PubMed ID: 32531256
[TBL] [Abstract][Full Text] [Related]
38. National registry for patients with inflammatory rheumatic diseases (IRD) infected with SARS-CoV-2 in Germany (ReCoVery): a valuable mean to gain rapid and reliable knowledge of the clinical course of SARS-CoV-2 infections in patients with IRD.
Hasseli R; Mueller-Ladner U; Schmeiser T; Hoyer BF; Krause A; Lorenz HM; Regierer AC; Richter JG; Strangfeld A; Voll RE; Pfeil A; Schulze-Koops H; Specker C
RMD Open; 2020 Sep; 6(2):. PubMed ID: 32878994
[TBL] [Abstract][Full Text] [Related]
39. Safety and Efficacy of Imatinib for Hospitalized Adults with COVID-19: A structured summary of a study protocol for a randomised controlled trial.
Emadi A; Chua JV; Talwani R; Bentzen SM; Baddley J
Trials; 2020 Oct; 21(1):897. PubMed ID: 33115543
[TBL] [Abstract][Full Text] [Related]
40. SARS-CoV-2, which induces COVID-19, causes kawasaki-like disease in children: role of pro-inflammatory and anti-inflammatory cytokines.
Ronconi G; Teté G; Kritas SK; Gallenga CE; Caraffa Al; Ross R; Conti P
J Biol Regul Homeost Agents; 2020 May-June,; 34(3):767-773. PubMed ID: 32476380
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
